65 related articles for article (PubMed ID: 16906022)
1. Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients.
Xiang X; Jada SR; Li HH; Fan L; Tham LS; Wong CI; Lee SC; Lim R; Zhou QY; Goh BC; Tan EH; Chowbay B
Pharmacogenet Genomics; 2006 Sep; 16(9):683-91. PubMed ID: 16906022
[TBL] [Abstract][Full Text] [Related]
2. CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients.
Lal S; Sandanaraj E; Wong ZW; Ang PC; Wong NS; Lee EJ; Chowbay B
Cancer Sci; 2008 Oct; 99(10):2045-54. PubMed ID: 19016765
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association meta-analysis for total serum bilirubin levels.
Johnson AD; Kavousi M; Smith AV; Chen MH; Dehghan A; Aspelund T; Lin JP; van Duijn CM; Harris TB; Cupples LA; Uitterlinden AG; Launer L; Hofman A; Rivadeneira F; Stricker B; Yang Q; O'Donnell CJ; Gudnason V; Witteman JC
Hum Mol Genet; 2009 Jul; 18(14):2700-10. PubMed ID: 19414484
[TBL] [Abstract][Full Text] [Related]
4. Effects of
Song G; Chung JE; Yee J; Lee KE; Park K; Gwak HS
J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575639
[No Abstract] [Full Text] [Related]
5. Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure.
Tsuboya A; Kubota Y; Ishida H; Ohkuma R; Ishiguro T; Hirasawa Y; Ariizumi H; Tsunoda T; Sasaki Y; Matsumoto N; Kondo Y; Tomoda Y; Kusuhara H; Fujita KI
Cancer Chemother Pharmacol; 2021 Sep; 88(3):543-553. PubMed ID: 34117512
[TBL] [Abstract][Full Text] [Related]
6. High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.
Yamada Y; Fujii H; Ohata K; Kato-Hayashi H; Watanabe D; Ishihara T; Uemura S; Iwashita T; Imai H; Matsuhashi N; Takahashi T; Sugiyama T; Shimizu M; Yoshida K; Suzuki A
Med Oncol; 2019 Jun; 36(7):63. PubMed ID: 31161433
[TBL] [Abstract][Full Text] [Related]
7. Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.
Schulte RR; Ho RH
Mol Pharmacol; 2019 May; 95(5):490-506. PubMed ID: 30782852
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China.
Zhong Z; Wu H; Li B; Li C; Liu Z; Yang M; Zhang Q; Zhong W; Zhao P
J Clin Lab Anal; 2018 Jul; 32(6):e22408. PubMed ID: 29424099
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
Ahmed S; Zhou Z; Zhou J; Chen SQ
Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.
Kulkarni P; Korzekwa K; Nagar S
J Pharmacol Exp Ther; 2016 Oct; 359(1):26-36. PubMed ID: 27451408
[TBL] [Abstract][Full Text] [Related]
11. SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.
Luo JQ; He FZ; Wang ZM; Sun NL; Wang LY; Tang GF; Liu MZ; Li Q; Chen XP; Liu ZQ; Zhou HH; Zhang W
Sci Rep; 2015 Nov; 5():17253. PubMed ID: 26607661
[TBL] [Abstract][Full Text] [Related]
12. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer.
Fujita K; Kubota Y; Ishida H; Sasaki Y
World J Gastroenterol; 2015 Nov; 21(43):12234-48. PubMed ID: 26604633
[TBL] [Abstract][Full Text] [Related]
13. Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients.
Agarwal G; Tulsyan S; Lal P; Mittal B
World J Surg; 2016 Jul; 40(7):1600-10. PubMed ID: 26506825
[TBL] [Abstract][Full Text] [Related]
14. Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.
Crona DJ; Ramirez J; Qiao W; de Graan AJ; Ratain MJ; van Schaik RH; Mathijssen RH; Rosner GL; Innocenti F
Pharmacogenomics J; 2016 Feb; 16(1):54-9. PubMed ID: 25869015
[TBL] [Abstract][Full Text] [Related]
15. Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy.
Thakkar N; Lockhart AC; Lee W
AAPS J; 2015 May; 17(3):535-45. PubMed ID: 25735612
[TBL] [Abstract][Full Text] [Related]
16. Application of a combination of a knowledge-based algorithm and 2-stage screening to hypothesis-free genomic data on irinotecan-treated patients for identification of a candidate single nucleotide polymorphism related to an adverse effect.
Takahashi H; Sai K; Saito Y; Kaniwa N; Matsumura Y; Hamaguchi T; Shimada Y; Ohtsu A; Yoshino T; Doi T; Okuda H; Ichinohe R; Takahashi A; Doi A; Odaka Y; Okuyama M; Saijo N; Sawada J; Sakamoto H; Yoshida T
PLoS One; 2014; 9(8):e105160. PubMed ID: 25127363
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.
Panczyk M
World J Gastroenterol; 2014 Aug; 20(29):9775-827. PubMed ID: 25110414
[TBL] [Abstract][Full Text] [Related]
18. SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer.
Huang L; Zhang T; Xie C; Liao X; Yu Q; Feng J; Ma H; Dai J; Li M; Chen J; Zang A; Wang Q; Ge S; Qin K; Cai J; Yuan X
PLoS One; 2013; 8(10):e77223. PubMed ID: 24143213
[TBL] [Abstract][Full Text] [Related]
19. The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.
Tsakalozou E; Adane ED; Kuo KL; Daily A; Moscow JA; Leggas M
Drug Metab Dispos; 2013 Jul; 41(7):1404-13. PubMed ID: 23620484
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
